Status:

COMPLETED

A Follow-up Study on Safety and Tolerability of Intracerebroventricular Administration of sNN0031 to Patients With Parkinson's Disease

Lead Sponsor:

Newron Sweden AB

Collaborating Sponsors:

Medtronic

TFS Trial Form Support

Conditions:

Parkinson's Disease

Eligibility:

All Genders

30-75 years

Brief Summary

The purpose of this study is to document the long-term safety and tolerability after intracerebroventricular (ICV) administration of sNN0031 (PDGF-BB) in patients who participated in study sNN0031-001

Eligibility Criteria

Inclusion

  • Previous participation in study sNN0031-001 with completion of 12 study weeks without development of clinically significant safety concerns, defined as being any drug-related or device related serious adverse event that resulted in premature termination of treatment or a medical device incident that could not be resolved during the conduct of study sNN0031-001
  • The patient has a diagnosis of idiopathic PD
  • The patient has been given written and verbal information about the follow-up study, has had the opportunity to ask questions about the study, and understands the time and procedural commitments
  • The patient has provided written informed consent to participate in the follow-up study

Exclusion

  • The patient has been included or participates in another clinical study after participation in Study sNN0031-001
  • The patient has, since participation in study sNN0031-001, had functional neurosurgical treatment for PD (e.g., deep brain stimulation).
  • Patients will only be excluded from participation in the event of a laboratory test abnormality that is indicative of a medical condition requiring treatment which, in the opinion of the investigator, is not compatible with participation in the present study

Key Trial Info

Start Date :

August 1 2011

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

August 1 2014

Estimated Enrollment :

11 Patients enrolled

Trial Details

Trial ID

NCT01807338

Start Date

August 1 2011

End Date

August 1 2014

Last Update

October 9 2014

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Department of Neurology, Skåne University Hospital

Lund, Sweden, 221 85